Dr Laurence is pursuing the pathophysiology of cardiovascular and skeletal abnormalities linked to HIV disease and its therapies at Weill Cornell. Dr Laurence is the editor-in-chief of Translational Medicine, which Elsevier co-publishes with the CSCTR.

• 1. Introduction (TBA)2. Epigenetics and muscle function in COPD (Esther Barreiro, M.D., Ph.D.)3. Epigenetics of pulmonary fibrosis (David Schwartz, MD; Ivana Yang, PhD)4. Epigenetics in acute kidney injury and renal cancer (Gregory Dressler, Ph.D.)5. Epigenetic mechanisms of carcinogenesis (Max Costa, Ph.D.)6. Epigenetics of epithelial-to-mesenchymal-transition in breast cancer (Sonja C. Stadler, PhD)7. Maria E. Figueroa, M.D. (Epigenetics of leukemia)8. Epigenetics of diabetes (Carmella Evans-Molina, MD, PhD)9. Epigenetic control of fetal hemoglobin (Gordon D. Ginder, MD)10. Nucleosome remodeling and deacetylase (NuRD) complex in development and disease (Michael Rauchman, MD)11. RNA epigenetics (Tao Pan, PhD)12. Epigenetics in immune-related diseases (Xiao-Feng Yang, MD, PhD, FAHA)13. Epigenetics of dementia in aging (David A. Bennett, MD)14. Epigenetics of aging (TBA)15. Epigenetics of stem cell reprogramming (TBA)16. Epigenetics in cardiovascular disease (TBA)17. Epigenetics and nutrition (TBA)18. Epigenetic effects of drug use (TBA)19. Epigenetics of inflammation (TBA)20. Epigenetics of lung cancer (TBA)21. Epigenetics and mitochondria (TBA)

"In a very innovative way, the authors start the exploration of the concept of epigenetic medicine as interventions to treat epigenetic disorders. Although epigenetics is the subject of multiple books currently, very few provide a link between causation, pathology, and intervention. These authors touch on the beginning of a new field in genomic medicine, which should be the subject of many publications in the future." --Doody's Review

Dr Laurence is pursuing the pathophysiology of cardiovascular and skeletal abnormalities linked to HIV disease and its therapies at Weill Cornell. Dr Laurence is the editor-in-chief of Translational Medicine, which Elsevier co-publishes with the CSCTR.

• 1. Introduction (TBA)2. Epigenetics and muscle function in COPD (Esther Barreiro, M.D., Ph.D.)3. Epigenetics of pulmonary fibrosis (David Schwartz, MD; Ivana Yang, PhD)4. Epigenetics in acute kidney injury and renal cancer (Gregory Dressler, Ph.D.)5. Epigenetic mechanisms of carcinogenesis (Max Costa, Ph.D.)6. Epigenetics of epithelial-to-mesenchymal-transition in breast cancer (Sonja C. Stadler, PhD)7. Maria E. Figueroa, M.D. (Epigenetics of leukemia)8. Epigenetics of diabetes (Carmella Evans-Molina, MD, PhD)9. Epigenetic control of fetal hemoglobin (Gordon D. Ginder, MD)10. Nucleosome remodeling and deacetylase (NuRD) complex in development and disease (Michael Rauchman, MD)11. RNA epigenetics (Tao Pan, PhD)12. Epigenetics in immune-related diseases (Xiao-Feng Yang, MD, PhD, FAHA)13. Epigenetics of dementia in aging (David A. Bennett, MD)14. Epigenetics of aging (TBA)15. Epigenetics of stem cell reprogramming (TBA)16. Epigenetics in cardiovascular disease (TBA)17. Epigenetics and nutrition (TBA)18. Epigenetic effects of drug use (TBA)19. Epigenetics of inflammation (TBA)20. Epigenetics of lung cancer (TBA)21. Epigenetics and mitochondria (TBA)

"In a very innovative way, the authors start the exploration of the concept of epigenetic medicine as interventions to treat epigenetic disorders. Although epigenetics is the subject of multiple books currently, very few provide a link between causation, pathology, and intervention. These authors touch on the beginning of a new field in genomic medicine, which should be the subject of many publications in the future." --Doody's Review

Dr Laurence is pursuing the pathophysiology of cardiovascular and skeletal abnormalities linked to HIV disease and its therapies at Weill Cornell. Dr Laurence is the editor-in-chief of Translational Medicine, which Elsevier co-publishes with the CSCTR.

• 1. Introduction (TBA)2. Epigenetics and muscle function in COPD (Esther Barreiro, M.D., Ph.D.)3. Epigenetics of pulmonary fibrosis (David Schwartz, MD; Ivana Yang, PhD)4. Epigenetics in acute kidney injury and renal cancer (Gregory Dressler, Ph.D.)5. Epigenetic mechanisms of carcinogenesis (Max Costa, Ph.D.)6. Epigenetics of epithelial-to-mesenchymal-transition in breast cancer (Sonja C. Stadler, PhD)7. Maria E. Figueroa, M.D. (Epigenetics of leukemia)8. Epigenetics of diabetes (Carmella Evans-Molina, MD, PhD)9. Epigenetic control of fetal hemoglobin (Gordon D. Ginder, MD)10. Nucleosome remodeling and deacetylase (NuRD) complex in development and disease (Michael Rauchman, MD)11. RNA epigenetics (Tao Pan, PhD)12. Epigenetics in immune-related diseases (Xiao-Feng Yang, MD, PhD, FAHA)13. Epigenetics of dementia in aging (David A. Bennett, MD)14. Epigenetics of aging (TBA)15. Epigenetics of stem cell reprogramming (TBA)16. Epigenetics in cardiovascular disease (TBA)17. Epigenetics and nutrition (TBA)18. Epigenetic effects of drug use (TBA)19. Epigenetics of inflammation (TBA)20. Epigenetics of lung cancer (TBA)21. Epigenetics and mitochondria (TBA)

"In a very innovative way, the authors start the exploration of the concept of epigenetic medicine as interventions to treat epigenetic disorders. Although epigenetics is the subject of multiple books currently, very few provide a link between causation, pathology, and intervention. These authors touch on the beginning of a new field in genomic medicine, which should be the subject of many publications in the future." --Doody's Review